XIB4035
(Synonyms:N-*4*-{7-氯-2-[2-(2-氯-苯基)-乙烯基]-喹啉-4-基}-N*1*,N*1*-二乙基-戊烷-1,4-二胺;阿米诺喹)
目录号 : KF1033
CAS No. : 10023-54-8
纯度 : 98%
XIB4035 (10023-54-8) is a novel small molecule thought to be an agonist at the glial cell line-derived neurotrophic factor (GDNF) family receptor GFRα-1. It inhibits radiolabeled GDNF binding in Neuro-2A cells in a concentration dependent manner IC50 = 10.4 μM. Like GDNF, XIB4035 induced Ret autophosphorylation and promoted neurite outgrowth in Neuro-2A cells. Recent studies indicate that it enhances GFRα family receptor signaling in conjunction with ligand stimulation. Effective treatment for small-fiber neuropathy in mouse models of the disease. GDNF agonists may be a new class of Parkinson’s disease therapeutics.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 分子式 |
C26H31Cl2N3 3(H3Po4)
|
| 分子量 |
750.45
|
| CAS号 |
10023-54-8
|
| 中文名称 |
阿米诺喹
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|